Skip to main content
Livermore
Livermore
ZHEN

Group One Trading, L.P.

SEC CIK
0000932540
Latest filing
Aug 13, 2026

ALDX holding history

Aldeyra Therapeutics, Inc. in every 13F filed by Group One Trading, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ALDX by Group One Trading, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−83,449−100.0%Sold outHolders
Q4 202583,449$432.3K<0.1%−30,135−26.5%ReducedHolders
Q3 2025113,584$592.9K<0.1%−19,403−14.6%ReducedHolders
Q2 2025132,987$509.3K<0.1%−31,424−19.1%ReducedHolders
Q1 2025164,411$945.4K<0.1%−39,740−19.5%ReducedHolders
Q4 2024204,151$1.02M<0.1%+174,719+593.6%AddedHolders
Q3 202429,432$158.6K<0.1%+27,586+1,494.4%AddedHolders
Q2 20241,846$6.11K<0.1%−4,200−69.5%ReducedHolders
Q1 20246,046$19.8K<0.1%−6,959−53.5%ReducedHolders
Q4 202313,005$45.6K<0.1%−52,541−80.2%ReducedHolders
Q3 202365,546$437.8K<0.1%+65,546NewHolders
Q2 20230$00.0%−100,909−100.0%Sold outHolders
Q1 2023100,909$1.00M<0.1%+86,292+590.4%AddedHolders
Q4 202214,617$101.7K<0.1%−11,296−43.6%ReducedHolders
Q3 202225,913$138.0K<0.1%+2,597+11.1%AddedHolders
Q2 202223,316$93.0K<0.1%−49,752−68.1%ReducedHolders
Q1 202273,068$325.0K<0.1%−5,800−7.4%ReducedHolders
Q4 202178,868$315.0K<0.1%−2,453−3.0%ReducedHolders
Q3 202181,321$714.0K<0.1%+81,321NewHolders
Q2 20210$00.0%−60,553−100.0%Sold outHolders
Q1 202160,553$719.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.